Microparticles and their emerging role in cancer multidrug resistance
Authors:
- J. GongJGJ. Gong
- R. JaiswalRJR. Jaiswal
- J.-M. MathysJMJ.-M. Mathys
- V. CombesVCV. Combes
- G.E.R. GrauGGG.E.R. Grau
- M. BebawyM. Bebawy
- 1 May 2012
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 38 (3) , 226-234
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1Biochemical Pharmacology, 2010
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cellsBiochemical Pharmacology, 2008
- Protection against cerebral malaria by the low-molecular-weight thiol pantethineProceedings of the National Academy of Sciences, 2008
- Function and role of microparticles in various clinical settingsThrombosis Research, 2008
- A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistanceProceedings of the National Academy of Sciences, 2007
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007
- miR-21-mediated tumor growthOncogene, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungalsCurrent Genetics, 1995